Preventative Chemotherapy: What the Term Can Mean
“Preventative chemotherapy” can be confusing because it is used informally for several different medical concepts. It does not mean that chemotherapy is routinely given to healthy people to prevent every type of cancer. The diagnosis, purpose, medicine and expected benefit must be explained by the specialist responsible for the person’s care.
Adjuvant and neoadjuvant chemotherapy
In cancer care, chemotherapy given after an operation or another primary treatment may be called adjuvant chemotherapy. Its purpose can be to reduce the chance of cancer returning by treating cells that may remain but cannot be seen on scans. Chemotherapy given before an operation may be called neoadjuvant chemotherapy and can be used to shrink or control a tumour before the next treatment.
Neither approach is automatically appropriate for a particular cancer. Recommendations depend on the cancer type and stage, pathology, biomarkers, previous treatment, general health and the balance between likely benefit and harm. Treatment length and medicines vary; a universal three-, six- or twelve-month timetable is misleading.
Cancer chemoprevention is a different concept
Chemoprevention generally refers to selected medicines used to reduce the chance of a cancer developing or returning in people with a defined risk. These medicines are not necessarily conventional cytotoxic chemotherapy. Their possible benefits and adverse effects depend on the drug, cancer risk and individual health.
Screening, vaccination and risk-reduction advice are also distinct from chemotherapy. A screening test does not itself prevent all cancer, and a preventive medicine should never be started on the basis of a blog or package offer.
WHO preventive chemotherapy for neglected tropical diseases
The World Health Organization also uses the term preventive chemotherapy for large-scale delivery of selected medicines to eligible population groups to control particular neglected tropical diseases. This public-health programme is not adjuvant cancer chemotherapy and should not be used as evidence for the effectiveness of cancer treatment.
See the WHO explanation of preventive chemotherapy for neglected tropical diseases. Statistics from these population programmes cannot be transferred to an individual’s cancer prognosis.
How chemotherapy decisions are made
An oncology team may consider pathology results, lymph-node involvement, tumour biology, evidence from relevant clinical trials and the person’s health and preferences. The discussion should cover the aim of treatment, absolute expected benefit, uncertainty, alternatives and what could happen without treatment.
No facilitator, travel company or unrelated clinician should select a chemotherapy regimen. If treatment abroad is being considered, the treating oncologists at home and at the destination should communicate directly, with access to pathology, imaging, medicine records and an emergency plan. Travel must not interrupt time-sensitive cancer care.
Possible side effects
Side effects depend on the medicine and dose. They may include tiredness, nausea or vomiting, sore mouth, bowel changes, hair loss, altered sensation, fertility effects, low blood counts, infection, anaemia, bleeding and blood clots. Some effects can be serious, delayed or long-lasting. Monitoring and supportive medicines should be part of the oncology plan.
The NHS explains that chemotherapy medicines and routes vary and that treatment may be used to cure cancer where possible, reduce recurrence, control spread or relieve symptoms. Read the current NHS chemotherapy guidance.
Urgent advice during treatment
Patients should follow the temperature and emergency instructions supplied by their own cancer team. Fever, chills or other signs of infection, unusual bleeding, severe vomiting or diarrhoea, new confusion, inability to drink or a rapidly worsening symptom should be reported promptly. Sudden breathlessness, chest pain, coughing blood, collapse or painful swelling in a limb requires urgent medical assessment.
Questions for the oncology team
- What is the exact diagnosis, stage and treatment aim?
- Is this adjuvant, neoadjuvant, palliative or another type of treatment?
- What benefit is expected for someone with my pathology and health?
- What are the important short- and long-term risks?
- How will blood tests, side effects and response be monitored?
- Could treatment affect fertility, pregnancy or other medicines?
- Who should I contact day and night if I become unwell?
- Would travel interfere with treatment or emergency access?
This page is general education, not an individual cancer recommendation. Revitalize must not replace advice from the oncology team or imply that an unrelated treatment package includes cancer care.